Inflammatory myofibroblastic tumor of the ureter in a paediatric patient

Abstract

Inflammatory myofibroblastic tumor (IMT) is a rare soft-tissue neoplasm which has been described in a variety of locations. In the urogenital system, it occurs mainly in the bladder and the kidney. IMT arising from the ureter is exceedingly rare. We report an exceptional case of IMT arising from the ureteric submucosa in a three-year-old female child. The patient presented with pan-hematuria and no other symptoms. Urinalysis revealed numerous red blood cells, culture was negative for infection. A CT Urogram showed the lesion was involving most of the ureter. A left radical nephroureterectomy was performed, and she has remained well to date. Ureteral IMT is extremely rare and often asymptomatic, which can result in a delayed diagnosis. Radical excision is the best therapeutic approach with excellent survival outcomes.

Keywords

Inflammatory myofibroblastic tumor / Ureteric tumor / Spindle cell neoplasm / Paediatric urology

CONFLICTS OF INTEREST DISCLOSURE

There is no conflict of interest.

References

[1] Fletcher C, Bridge J, Antonescu C, et al. WHO classification of tumours: soft tissue and bone tumours. 5. Lyon: International Agency for Research on Cancer; 2020. https://doi.org/10.32074/1591-951X-213

[2] Rabban JT, Zaloudek CJ, Shekitka KM, et al. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Am J Surg Pathol. 2005 Oct; 29(10): 1348-55. PMid:16160478. https://doi.org/10.1097/01.pas.0000172189.02424.91

[3] Freeman A, Geddes N, Munson P, et al. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. Mod Pathol. 2004; 17: 765-71. PMid:15105807. https://doi.org/10.1038/modpathol.3800078

[4] Bahadori M, Liebow AA. Plasma cell granulomas of the lung. Cancer. 1973 Jan; 31(1): 191-208. PMID: 4683037. https://doi.org/10.1002/1097-0142(197301)31:1＜191::AID-CNCR2820310127＞3.0.CO;2-D

[5] Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008 Apr; 61(4): 428-37. PMid:17938159. https://doi.org/10.1136/jcp.2007.049387

[6] Lai LM, McCarville MB, Kirby P, et al. Shedding light on inflammatory pseudotumor in children: spotlight on inflammatory myofibroblastic tumor. Pediatr Radiol. 2015 Nov; 45(12): 1738-52. PMid:25964134. https://doi.org/10.1007/s00247-015-3360-6

[7] Liu C, Zhao X, Zhao Z, et al. Malignant inflammatory myofibroblastic tumor of the prostate. J Clin Oncol. 2013 Apr 1; 31(10): e144-7. PMid:23401456. https://doi.org/10.1200/JCO.2012.44.48 51

[8] Tao YL, Wang ZJ, Han JG, et al. Inflammatory myofibroblastic tumor successfully treated with chemotherapy and nonsteroidals: a case report. World J Gastroenterol. 2012 Dec 21; 18(47): 7100-3. PMid:23323014. https://doi.org/10.3748/wjg.v18.i47.7100

[9] Brittig F, Ajtay E, Jaksó P, et al. Follicular dendritic reticulum cell tumor mimicking inflammatory pseudotumor of the spleen. Pathol. Oncol. Res. 2004; 10: 57-60. PMid:15029264. https://doi.org/10.1007/BF02893411

[10] Xiang J, Liu X, Wu S, et al. Multiple inflammatory myofibroblastic tumor of the duodenum: case report and literature review. J Gastrointest Surg. 2012 Jul; 16(7): 1442-5. PMid:22528570. https://doi.org/10.1007/s11605-012-1883-9

[11] Zhao JJ, Ling JQ, Fang Y, et al. Intra-abdominal inflammatory myofibroblastic tumor: spontaneous regression. World J Gastroenterol. 2014 Oct 7; 20(37): 13625-31. PMid:25309095. https://doi.org/10.3748/wjg.v20.i37.13625

[12] Wu S, Chen L, Wan Q, et al. Inflammatory myofibroblastic tumor of the urinary bladder in a patient with the left renal cell carcinoma: A case report. Exp Ther Med. 2014 Apr; 7(4): 1010-1012. PMid:24669268. https://doi.org/10.3892/etm.2014.1525

[13] Magro G, Salvatorelli L, Puzzo L, et al. Practical approach to diagnosis of bland-looking spindle cell lesions of the breast. Pathologica. 2019 Dec; 111(4): 344-360. PMid:31965112. https://doi.org/10.32074/1591-951X-31-19

[14] Groenveld RL, Raber MH, Oosterhof-Berktas R, et al. Abdominal inflammatory myofibroblastic tumor. Case Rep Gastroenterol. 2014 Mar 8; 8(1): 67-71. PMid:24707245. https://doi.org/10.1159/000360843

[15] Mossé YP, Voss SD, Lim MS, et al. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study. J Clin Oncol. 2017 Oct 1; 35(28): 3215-3221. PMid:28787259. https://doi.org/10.1200/JCO.2017.73.4830